Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Journal of Endocrinological Investigation
|
February 5, 2022
Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations
V Bonavolontà, L Cianferotti, G Iolascon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 27, 1998
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene
A Teti, A Taranta, S Migliaccio, et al.
Bone
|
February 22, 2002
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
A Taranta, M Brama, A Teti, et al.
The Journal of Nutrition
|
April 4, 2001
Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition
L Rossi, S Migliaccio, A Corsi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines
M Perez, S Migliaccio, A Taranta, et al.
Endocrinology
|
May 1, 1996
Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
S Migliaccio, R R Newbold, B C Bullock, et al.
Endocrine
|
August 9, 2017
The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
F Marampon, C Antinozzi, C Corinaldesi, et al.
Journal of Endocrinological Investigation
|
July 3, 2015
Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
A Aversa, S Fittipaldi, V M Bimonte, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I Recchia, N Rucci, C Festuccia, et al.
The American Journal of Pathology
|
May 18, 1999
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders
A Fragale, M Tartaglia, S Bernardini, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Journal of Endocrinological Investigation
|
February 5, 2022
Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations
V Bonavolontà, L Cianferotti, G Iolascon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 27, 1998
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene
A Teti, A Taranta, S Migliaccio, et al.
Bone
|
February 22, 2002
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
A Taranta, M Brama, A Teti, et al.
The Journal of Nutrition
|
April 4, 2001
Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition
L Rossi, S Migliaccio, A Corsi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines
M Perez, S Migliaccio, A Taranta, et al.
Endocrinology
|
May 1, 1996
Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
S Migliaccio, R R Newbold, B C Bullock, et al.
Endocrine
|
August 9, 2017
The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
F Marampon, C Antinozzi, C Corinaldesi, et al.
Journal of Endocrinological Investigation
|
July 3, 2015
Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
A Aversa, S Fittipaldi, V M Bimonte, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I Recchia, N Rucci, C Festuccia, et al.
The American Journal of Pathology
|
May 18, 1999
Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders
A Fragale, M Tartaglia, S Bernardini, et al.
Page
of 7